Home › Immunoglobulin Light-chain Amyloidosis › New York › New York City
Immunoglobulin Light-chain Amyloidosis clinical trials in New York City, NY
4 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Teclistamab-Daratumumab in AL Amyloidosis
RecruitingPhase 2
- Columbia University Irving Medical Center, New York
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
RecruitingPhase 1/2
- Research Site, New York
- Research Site, New York
- Research Site, New York
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
RecruitingPhase 3
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
RecruitingObservational study
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Immunoglobulin Light-chain Amyloidosis trials in other cities
- Boston, MA7 studies
- Rochester, MN5 studies
- Durham, NC4 studies
- Cleveland, OH3 studies
- Columbus, OH3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.